| AMD | Age-related Macular Degeneration |
| GA | Geographic Atrophy |
| RPE | Retinal Pigment Epithelium |
| VEGF | Vascular Endothelial Growth Factor |
| FDA | Food and Drug Administration |
| CFH | Complement Factor H |
| ARMS2 | Age-Related Maculopathy Susceptibility 2 |
| HTRA1 | HtrA serine peptidase 1 |
| C3 | Complement component 3 |
| miRNAs | microRNAs |
| MNU | N-methyl-N-nitrosourea |
| ROS | Reactive oxygen species |
| BAX | Bcl-2-associated X protein |
| MCP | Monocyte Chemoattractant Protein |
| GFAP | Glial Fibrillary Acidic Protein |
| MMP | Matrix metalloproteinase |
| TIMP-3 | Tissue Inhibitor of Metalloproteinases-3 |
| ECM | Extracellular matrix |
| ANGP | Angiopoietin |
| SAA | Serum Amyloid A |
| CCL2 | Chemokine ligand 2 |
| EPO | Erythropoietin |
| SCFAs | Short-Chain Fatty Acids |
| LPS | Lipopolysaccharide |
| AAE | Aronia Anthocyanidin Extract |
| C-X3-C | Motif Chemokine Receptor 1 |
| VLDRL | Very low-density lipoprotein receptor |
| 8-OHDG | 8-hydroxy-2′-deoxyguanosine |
| IRAK-M | interleukin-1 receptor–associated kinase M |
| AAV | Adeno-Associated Virus |
| BrM | Bruch’s membrane |
| SNP | Single Nucleotide Polymorphism |
| MNV | Macular Neovascularization |
| THBS2 | Thrombospondin 2 |
| DHA | Docosahexaenoic Acid |
| CEP | Carboxyethyl Pyrrole |
| MDA | Malondialdehyde |
| CRP | C-reactive protein |
| SMOC2 | Secreted Modular Calcium-binding protein 2 |
| SD-OCT | Spectral-Domain Optical Coherence Tomography |
| IRF | Intraretinal Fluid |
| SRF | Subretinal Fluid |
| PEDs | Pigment Epithelial Detachments |